文献速递主动脉疾病

肝素在钝性胸主动脉损伤血管内修复中的作用

The role of heparin in endovascular repair of blunt thoracic aortic injury.
PubMed 文献 · J Vasc Surg · 2019-05-18

本研究回顾性分析15年间77例钝性胸主动脉损伤行TEVAR的患者,比较全量、低剂量和无肝素三组结局。三组血栓栓塞、出血和死亡率相当,无肝素组修复时间更短且ICU时间更短。

要点

  • 无肝素TEVAR在BTAI中安全可行,尤其适用于多发伤患者
  • 无肝素组从入院到修复时间更短,ICU时间更短
  • 三组血栓栓塞、出血和死亡率无显著差异

核心结论

  • 肝素化与非肝素化组结局无统计学显著差异,无肝素组主要获益在于修复时间更短。
  • 无肝素化似乎是安全且可能更快的替代方案,尤其对多发伤患者。

研究设计与样本

  • 回顾性分析15年(2003年3月至2017年9月)高容量城市创伤中心77例确诊BTAI行TEVAR的病例。
  • 按术中肝素使用分为全量肝素组(42例)、低剂量肝素组(18例)和无肝素组(17例)。

主要发现

  • 三组年龄、性别、BMI、吸烟史无显著差异,最常见损伤机制为机动车碰撞。
  • 三组血栓栓塞、出血结局和死亡率相当,57例继续随访平均30.99个月。

临床怎么用

  • 危重BTAI患者行TEVAR时术中肝素化仍由外科医生决定。
  • 无肝素化可作为安全且可能更快的替代方案,尤其适用于多发伤患者。

局限性

  • 回顾性研究设计,样本量较小(共77例),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early diagnosis and treatment are essential to improve survival of patients with blunt thoracic aortic injury (BTAI). Often, aortic surgical intervention may be delayed because of increased risk of bleeding with heparin, particularly in polytrauma victims. We believe that surgical delay may be remedied by proceeding without heparinization. This study reviewed the outcome of patients subjected to thoracic endovascular aortic repair (TEVAR) under full, low-dose, and no intraoperative systemic heparinization. METHODS: There were 77 cases of confirmed BTAI identified and retrospectively analyzed at a high-volume urban trauma center during a period of 15 years (March 2003-September 2017). Patients were stratified into three groups on the basis of the intraoperative use of heparin during TEVAR, as follows: full heparin (FH), low-dose heparin (LH), and no heparin (NH). Baseline characteristics including the patients' demographics, diagnostic laboratory data and imaging studies, operative reports, postoperative complications, embolic and bleeding outcomes, and mortality data were reviewed. RESULTS: Of the 77 total patients who underwent TEVAR for BTAI, 42 patients received full-dose heparinization, 18 received low-dose heparin, and 17 had no use of systemic heparin. There was no significant difference in age, sex, body mass index, or smoking history. The most common mechanism of injury was motor vehicle collision. Grade 3 (pseudoaneurysm) was the predominant type of BTAI (FH, 69.0%; LH, 61.1%; NH, 76.5%; P = .23). The mean interval between admission and repair was three times longer in the FH group than in the NH group (FH, 2.33 days; NH, 0.76 day; P = .091). The mean time in the intensive care unit was shorter in the NH group vs the FH group (15 days vs 26.21 days; P = .025). Thromboembolic and bleeding outcomes and mortality rates were comparable in all three groups; 57 patients continued follow-up for a mean time of 30.99 months. CONCLUSIONS: Our study shows no statistically significant difference in outcomes between the heparinized and nonheparinized groups. The primary benefit of the NH group is seen in time to repair. Although not statistically significant, the mean time to repair was three times longer in the FH group. Patients in the NH group also benefited from prompt intervention and treatment. Therefore, intraoperative heparinization in critically ill patients with BTAI undergoing TEVAR remains at the surgeon's discretion, although the lack of heparinization appears to be a safe and potentially faster alternative, particularly in the polytrauma patient.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kenel-Pierre S, Ramos Duran E, Abi-Chaker A, et al. The role of heparin in endovascular repair of blunt thoracic aortic injury. J Vasc Surg. 2019. PMID: 31113724. doi:10.1016/j.jvs.2019.01.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。